scholarly journals Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

2012 ◽  
Vol 12 (5) ◽  
pp. 388-396 ◽  
Author(s):  
R McGready ◽  
SJ Lee ◽  
J Wiladphaingern ◽  
EA Ashley ◽  
MJ Rijken ◽  
...  
2018 ◽  
Vol 35 (7) ◽  
pp. 981-992 ◽  
Author(s):  
Anna Cantarutti ◽  
Matteo Franchi ◽  
Federico Rea ◽  
Luca Merlino ◽  
Giovanni Corrao

2021 ◽  
Vol 14 (3) ◽  
pp. 191-197
Author(s):  
Satya Sree Rallabandi ◽  
Sai Samanth Makula ◽  
Vasudeva Murthy Sindgi ◽  
Bandari Jagadeesh Babu ◽  
Usha Sree Puneem

2006 ◽  
Vol 193 (1) ◽  
pp. 9-15 ◽  
Author(s):  
Moses R. Kamya ◽  
Anne F. Gasasira ◽  
Adoke Yeka ◽  
Nathan Bakyaita ◽  
Samuel L. Nsobya ◽  
...  

2012 ◽  
Vol 24 (3) ◽  
pp. 594-601 ◽  
Author(s):  
S. Berntsen ◽  
K. R. Richardsen ◽  
K. Mørkrid ◽  
L. Sletner ◽  
K. I. Birkeland ◽  
...  

2019 ◽  
Vol 75 (8) ◽  
pp. 1153-1160 ◽  
Author(s):  
Arton Baftiu ◽  
Maren H. Lima ◽  
Kristian Svendsen ◽  
Pål G. Larsson ◽  
Svein I. Johannessen ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (11) ◽  
pp. 1307
Author(s):  
Ileana Baldi ◽  
Danila Azzolina ◽  
Andrea Francavilla ◽  
Patrizia Bartolotta ◽  
Giulia Lorenzoni ◽  
...  

Several European countries suspended or changed recommendations for the use of Vaxzevria (AstraZeneca) for suspected adverse effects due to atypical blood-clotting. This research aims to identify a reference point towards the number of thrombotic events expected in the Italian population over 50 years of age who received Vaxzevria from 22 January to 12 April 2021. The venous thromboembolism (VT) and immune thrombocytopenia (ITP) event rates were estimated from a population-based cohort. The overall VT rate was 1.15 (95% CI 0.93–1.42) per 1000 person-years, and the ITP rate was 2.7 (95% CI 0.7–11) per 100,000 person-years. These figures translate into 83 and two expected events of VT and ITP, respectively, in the 15 days following the first administration of Vaxzevria. The number of thrombotic events reported from the Italian Medicines Agency does not appear to have increased beyond that expected in individuals over 50 years of age.


2017 ◽  
Vol 116 (4) ◽  
pp. 500-506 ◽  
Author(s):  
Jón Örn Fridriksson ◽  
Yasin Folkvaljon ◽  
Karl-Johan Lundström ◽  
David Robinson ◽  
Stefan Carlsson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document